Originally published to the March STR/SOR Newsletter Thu, Mar 28, 2019 5:54 pm
2019. Graph from Alex Duello, Evaluation Coordinator, State Opioid Response, UMSL-MIMH
The graph above represents two key outcomes - six month treatment retention and median monthly cost - from evaluation of the first nine months of treatment delivery under the STR grant (July, 2017 to March, 2018). STR treatment data is compared to data from STR-contracted treatment agencies from the first nine months of the year prior to STR. Numbers reflect episodes of care (EOCs) for uninsured individuals with an Opioid Use Disorder (OUD) only. Through STR, six month treatment retention more than doubled, while the median monthly price of treatment decreased 19%. The median monthly price of treatment reflects costs incurred to the State and includes costs of all services delivered within an EOC (e.g., medication, counseling, case management, administrative incentive payments). Though monthly costs are lower during STR, overall EOC costs across pre-STR and STR are the same or higher during STR because people are staying in treatment longer. As longer retention is our shared clinical goal in the treatment of any chronic condition, we assessed monthly costs instead of full EOC costs when making cost comparisons.